You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
SAN FRANCISCO, Oct. 29 - The GlaxoSmithKline alliance with Exelixis announced Monday validates the use of genomics in drug discovery and could lead to similar deals, said Exelixis Chief Scientific Officer Geoffrey Duyk.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
New analyses indicate female researchers are publishing less during the coronavirus pandemic than male researchers, according to Nature News.
A study suggests people with the ApoE e4 genotype may be more likely to have severe COVID-19 than those with other genotypes, the Guardian says.
Direct-to-consumer genetic testing companies are searching for a genetic reason for why some people, but not others, become gravely ill with COVID-19, the Detroit Free Press reports.
In PNAS this week: forward genetics-base analysis of retinal development, interactions of T cell receptors with neoantigens in colorectal cancer, and more.